- Markets
- Chemicals
- PRIVISCL
PRIVISCL
New to Zerodha? Sign-up for free.
New to Zerodha? Sign-up for free.
-
Share Price
-
Financials
-
Revenue mix
-
Shareholdings
-
Peers
-
Forensics
- 5D
- 1M
- 6M
- YTD
- 1Y
- 5Y
- MAX
This data is currently unavailable for this company.
-
Summary
-
Profit & Loss
-
Balance sheet
-
Cashflow
This data is currently unavailable for this company.
| (In Cr.) |
|---|
| (In Cr.) | ||||
|---|---|---|---|---|
|
This data is currently unavailable for this company. |
| (In %) |
|---|
| (In Cr.) |
|---|
| Financial Year (In Cr.) |
|---|
-
Product wise
-
Location wise
Revenue Mix
This data is currently unavailable for this company.
Revenue Mix
This data is currently unavailable for this company.
Recent events
-
News
-
Corporate Actions
India's Privi Specialty hits near 2-1/2 yr high on Q2 profit rise
** Shares of Privi Specialty Chemicals PIVI.NS rise as much as 5.5% to 1,808 rupees, highest since May 5, 2022
** Co said on Thursday its consol net profit rose 46% to 446.6 mln rupees ($5.31 mln) Y/Y
** Rev from ops up 17%
** More than 138,000 shares change hands, 2.7x its 30-day avg
** Stock up 50% so far this year
($1 = 84.0480 Indian rupees)
(Reporting by Ashna Teresa Britto in Bengaluru)
(([email protected] ; ( +91 8078332441))
** Shares of Privi Specialty Chemicals PIVI.NS rise as much as 5.5% to 1,808 rupees, highest since May 5, 2022
** Co said on Thursday its consol net profit rose 46% to 446.6 mln rupees ($5.31 mln) Y/Y
** Rev from ops up 17%
** More than 138,000 shares change hands, 2.7x its 30-day avg
** Stock up 50% so far this year
($1 = 84.0480 Indian rupees)
(Reporting by Ashna Teresa Britto in Bengaluru)
(([email protected] ; ( +91 8078332441))
Privi Speciality Chemicals Gets API, Registration Certificate For Its Camphor Product From US FDA
Oct 10 (Reuters) - Privi Speciality Chemicals Ltd PIVI.NS:
PRIVI SPECIALITY CHEMICALS- GOT API, REGISTRATION CERTIFICATE FOR ITS CAMPHOR PRODUCT FROM US FDA
Source text for Eikon: ID:nNSE87yk3z
Further company coverage: PIVI.NS
(([email protected];))
Oct 10 (Reuters) - Privi Speciality Chemicals Ltd PIVI.NS:
PRIVI SPECIALITY CHEMICALS- GOT API, REGISTRATION CERTIFICATE FOR ITS CAMPHOR PRODUCT FROM US FDA
Source text for Eikon: ID:nNSE87yk3z
Further company coverage: PIVI.NS
(([email protected];))
India's Privi Speciality Chemicals at 22-month high on Q1 profit jump
** Shares of Privi Speciality Chemicals PIVI.NS rise as much as 5.8% to 1,720 rupees
** Stock hits highest since Sept 2022, eyes fourth straight session of gains
** Aroma and fragrance chemicals maker reports near 7-fold jump in Q1 consolidated net profit
** More than 206,000 shares traded, 3.3x the 30-day avg
** Stock last up 2%, taking YTD gains to 40.8%
(Reporting by Anisha Ajith in Bengaluru)
(([email protected];))
** Shares of Privi Speciality Chemicals PIVI.NS rise as much as 5.8% to 1,720 rupees
** Stock hits highest since Sept 2022, eyes fourth straight session of gains
** Aroma and fragrance chemicals maker reports near 7-fold jump in Q1 consolidated net profit
** More than 206,000 shares traded, 3.3x the 30-day avg
** Stock last up 2%, taking YTD gains to 40.8%
(Reporting by Anisha Ajith in Bengaluru)
(([email protected];))
Privi Speciality Chemicals- Got Government Conferred Status Of Ultra Mega Project
Privi Speciality Chemicals Ltd PIVI.NS:
PRIVI SPECIALITY CHEMICALS- GOT GOVERNMENT CONFERRED STATUS OF ULTRA MEGA PROJECT
Source text for Eikon: ID:nBSE3L6Sgt
Further company coverage: PIVI.NS
Privi Speciality Chemicals Ltd PIVI.NS:
PRIVI SPECIALITY CHEMICALS- GOT GOVERNMENT CONFERRED STATUS OF ULTRA MEGA PROJECT
Source text for Eikon: ID:nBSE3L6Sgt
Further company coverage: PIVI.NS
Privi Speciality Chemicals Is Exploring Strategic Investment In Privi Fine Sciences
June 24 (Reuters) - Privi Speciality Chemicals Ltd PIVI.NS:
CO IS EXPLORING STRATEGIC INVESTMENT IN PRIVI FINE SCIENCES
DEAL FOR 2.98 BILLION RUPEES
Source text for Eikon: ID:nBSE7KfvzN
Further company coverage: PIVI.NS
(([email protected];;))
June 24 (Reuters) - Privi Speciality Chemicals Ltd PIVI.NS:
CO IS EXPLORING STRATEGIC INVESTMENT IN PRIVI FINE SCIENCES
DEAL FOR 2.98 BILLION RUPEES
Source text for Eikon: ID:nBSE7KfvzN
Further company coverage: PIVI.NS
(([email protected];;))
Privi Speciality Chemicals Declared Dividend 2 Rupees Per Share
May 2 (Reuters) - Privi Speciality Chemicals Ltd PIVI.NS:
DIVIDEND 2 RUPEES PER SHARE
REAPPOINTED MAHESH P BABANI AS A CHAIRMAN AND MANAGING DIRECTOR OF CO
MARCH-QUARTER CONSOL NET PROFIT 310.2 MILLION RUPEES VERSUS LOSS 136.8 MILLION RUPEES
MARCH-QUARTER CONSOL REVENUE FROM OPERATIONS 4.84 BILLION RUPEES VERSUS 3.99 BILLION RUPEES
APPROVED TO ISSUE SECURITIES WORTH UPTO 10 BILLION RUPEES
Further company coverage: PIVI.NS
(([email protected];))
May 2 (Reuters) - Privi Speciality Chemicals Ltd PIVI.NS:
DIVIDEND 2 RUPEES PER SHARE
REAPPOINTED MAHESH P BABANI AS A CHAIRMAN AND MANAGING DIRECTOR OF CO
MARCH-QUARTER CONSOL NET PROFIT 310.2 MILLION RUPEES VERSUS LOSS 136.8 MILLION RUPEES
MARCH-QUARTER CONSOL REVENUE FROM OPERATIONS 4.84 BILLION RUPEES VERSUS 3.99 BILLION RUPEES
APPROVED TO ISSUE SECURITIES WORTH UPTO 10 BILLION RUPEES
Further company coverage: PIVI.NS
(([email protected];))
Privi Speciality Chemicals To Consider And Approve Raising Of Funds
April 22 (Reuters) - Privi Speciality Chemicals Ltd PIVI.NS:
PRIVI SPECIALITY CHEMICALS LTD - TO CONSIDER AND APPROVE RAISING OF FUNDS
Source text for Eikon: ID:nBSE9BbqcJ
Further company coverage: PIVI.NS
(([email protected];))
April 22 (Reuters) - Privi Speciality Chemicals Ltd PIVI.NS:
PRIVI SPECIALITY CHEMICALS LTD - TO CONSIDER AND APPROVE RAISING OF FUNDS
Source text for Eikon: ID:nBSE9BbqcJ
Further company coverage: PIVI.NS
(([email protected];))
India's Ami Organics rises on $60 mln fund raise plan
** Shares of Ami Organics AMIO.NS up as much as 2.8% to 1,255 rupees; last up 1.7%
** The speciality chemicals maker on Friday approved raising 5 bln rupees ($59.9 mln) via qualified institutional placement (QIP) of shares
** Average rating of five analysts covering the stock is "buy"; median PT is 1,315 rupees - LSEG data
** Including session's moves, AMIO up ~11% this year, far outpacing rivals Privi Speciality Chemicals PIVI.NS and Tatva Chintan Pharma Chem TATV.NS, which are down between 7.1%-21.8%
($1 = 83.4300 Indian rupees)
(Reporting by Navamya Ganesh Acharya in Bengaluru)
(([email protected]; +91 8805175330 ;))
** Shares of Ami Organics AMIO.NS up as much as 2.8% to 1,255 rupees; last up 1.7%
** The speciality chemicals maker on Friday approved raising 5 bln rupees ($59.9 mln) via qualified institutional placement (QIP) of shares
** Average rating of five analysts covering the stock is "buy"; median PT is 1,315 rupees - LSEG data
** Including session's moves, AMIO up ~11% this year, far outpacing rivals Privi Speciality Chemicals PIVI.NS and Tatva Chintan Pharma Chem TATV.NS, which are down between 7.1%-21.8%
($1 = 83.4300 Indian rupees)
(Reporting by Navamya Ganesh Acharya in Bengaluru)
(([email protected]; +91 8805175330 ;))
Privi Speciality Chemicals Dec-Quarter Consol Net Profit Rises
Jan 25 (Reuters) - Privi Speciality Chemicals Ltd PIVI.NS:
PRIVI SPECIALITY CHEMICALS DEC-QUARTER CONSOL NET PROFIT 287.6 MILLION RUPEES VERSUS PROFIT 56.4 MILLION RUPEES
PRIVI SPECIALITY CHEMICALS DEC-QUARTER CONSOL REVENUE FROM OPERATIONS 4.04 BILLION RUPEES VERSUS 4.20 BILLION RUPEES
Source text for Eikon: ID:nBSE46mgrz
Further company coverage: PIVI.NS
(([email protected];))
Jan 25 (Reuters) - Privi Speciality Chemicals Ltd PIVI.NS:
PRIVI SPECIALITY CHEMICALS DEC-QUARTER CONSOL NET PROFIT 287.6 MILLION RUPEES VERSUS PROFIT 56.4 MILLION RUPEES
PRIVI SPECIALITY CHEMICALS DEC-QUARTER CONSOL REVENUE FROM OPERATIONS 4.04 BILLION RUPEES VERSUS 4.20 BILLION RUPEES
Source text for Eikon: ID:nBSE46mgrz
Further company coverage: PIVI.NS
(([email protected];))
Privi Speciality Chemicals Says Invested Second Tranche Of 36.5 Million Rupees In SPV
Aug 7 (Reuters) - Privi Speciality Chemicals Ltd PIVI.NS:
CO INVESTED SECOND TRANCHE OF 36.5 MILLION RUPEES IN SPV
Source text for Eikon: ID:nNSE8tv3wV
Further company coverage: PIVI.NS
(([email protected];))
Aug 7 (Reuters) - Privi Speciality Chemicals Ltd PIVI.NS:
CO INVESTED SECOND TRANCHE OF 36.5 MILLION RUPEES IN SPV
Source text for Eikon: ID:nNSE8tv3wV
Further company coverage: PIVI.NS
(([email protected];))
India's Privi Speciality Chemicals Posts March-Quarter Consol Net Loss
May 29 (Reuters) - Privi Speciality Chemicals Ltd PIVI.NS:
INDIA'S PRIVI SPECIALITY CHEMICALS LTD MARCH-QUARTER CONSOL NET LOSS 136.8 MILLION RUPEES VERSUS PROFIT 299.1 MILLION RUPEES
PRIVI SPECIALITY CHEMICALS LTD MARCH-QUARTER CONSOL REVENUE FROM OPERATIONS 3.99 BILLION RUPEES VERSUS 3.77 BILLION RUPEES
Source text for Eikon: [ID:]
Further company coverage: PIVI.NS
(([email protected];))
May 29 (Reuters) - Privi Speciality Chemicals Ltd PIVI.NS:
INDIA'S PRIVI SPECIALITY CHEMICALS LTD MARCH-QUARTER CONSOL NET LOSS 136.8 MILLION RUPEES VERSUS PROFIT 299.1 MILLION RUPEES
PRIVI SPECIALITY CHEMICALS LTD MARCH-QUARTER CONSOL REVENUE FROM OPERATIONS 3.99 BILLION RUPEES VERSUS 3.77 BILLION RUPEES
Source text for Eikon: [ID:]
Further company coverage: PIVI.NS
(([email protected];))
Privi Speciality Chemicals Invested First Tranche Of 1 Mln Rupees By Subscribing To Shares
May 4 (Reuters) - Privi Speciality Chemicals Ltd PIVI.NS:
INVESTED FIRST TRANCHE OF 1 MILLION RUPEES BY SUBSCRIBING TO SHARES
Source text for Eikon: [ID:]
Further company coverage: PIVI.NS
(([email protected];))
May 4 (Reuters) - Privi Speciality Chemicals Ltd PIVI.NS:
INVESTED FIRST TRANCHE OF 1 MILLION RUPEES BY SUBSCRIBING TO SHARES
Source text for Eikon: [ID:]
Further company coverage: PIVI.NS
(([email protected];))
Upcoming Events:
Quarterly Results
Events:
Dividend
Dividend
Dividend
Dividend
Dividend
Dividend
Dividend
Dividend
Dividend
Bonus
Dividend
More Small Cap Ideas
See similar 'Small' cap companies with recent activity
Promoter Buying
Companies where the promoters are bullish
Capex
Companies investing on expansion
Superstar Investor
Companies where well known investors have invested
Popular questions
-
Business
-
Financials
-
Share Price
-
Shareholdings
What does Privi Speciality Che do?
Adi Finechem Ltd is a technology-driven company specializing in oleo chemicals and products for the nutraceutical industry. They offer a range of products including mixed tocopherols, sterols, linoleic acid, monobasic acid, and dimer acid for various industries.
Who are the competitors of Privi Speciality Che?
Privi Speciality Che major competitors are Rossari Biotech, SH Kelkar & Co, Clean Science, Oriental Aromatics, Dynemic Products, Jocil, Atul. Market Cap of Privi Speciality Che is ₹7,370 Crs. While the median market cap of its peers are ₹2,932 Crs.
Is Privi Speciality Che financially stable compared to its competitors?
Privi Speciality Che seems to be less financially stable compared to its competitors. Altman Z score of Privi Speciality Che is 4.77 and is ranked 5 out of its 8 competitors.
Does Privi Speciality Che pay decent dividends?
The company seems to be paying a very low dividend. Investors need to see where the company is allocating its profits. Privi Speciality Che latest dividend payout ratio is 8.23% and 3yr average dividend payout ratio is 8.13%
How has Privi Speciality Che allocated its funds?
Companies resources are majorly tied in miscellaneous assets
How strong is Privi Speciality Che balance sheet?
Balance sheet of Privi Speciality Che is strong. But short term working capital might become an issue for this company.
Is the profitablity of Privi Speciality Che improving?
Yes, profit is increasing. The profit of Privi Speciality Che is ₹153 Crs for TTM, ₹94.91 Crs for Mar 2024 and ₹22.21 Crs for Mar 2023.
Is the debt of Privi Speciality Che increasing or decreasing?
Yes, The debt of Privi Speciality Che is increasing. Latest debt of Privi Speciality Che is ₹1,011 Crs as of Sep-24. This is greater than Mar-24 when it was ₹920 Crs.
Is Privi Speciality Che stock expensive?
Privi Speciality Che is not expensive. Latest PE of Privi Speciality Che is 48.65, while 3 year average PE is 76.48. Also latest EV/EBITDA of Privi Speciality Che is 20.52 while 3yr average is 25.72.
Has the share price of Privi Speciality Che grown faster than its competition?
Privi Speciality Che has given better returns compared to its competitors. Privi Speciality Che has grown at ~-2.36% over the last 3yrs while peers have grown at a median rate of -15.09%
Is the promoter bullish about Privi Speciality Che?
Promoters stake in the company seems stable, and we need to go through filings and allocation of resources to gauge promoter bullishness. Latest quarter promoter holding in Privi Speciality Che is 74.05% and last quarter promoter holding is 74.05%.
Are mutual funds buying/selling Privi Speciality Che?
The mutual fund holding of Privi Speciality Che is decreasing. The current mutual fund holding in Privi Speciality Che is 1.42% while previous quarter holding is 1.58%.